NCT03698045

Safety and Tolerability of PRO-143 Ophthalmic Solution in Healthy Volunteers.

Study to Evaluate the Safety and Tolerability of Pro-143 Ophthalmic Solution in Healthy Volunteers.

• Status: Withdrawn
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 0 (actual)
• Sponsor: Laboratorios Sophia S.A de C.V. · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Accepted

Summary

Study to evaluate the safety and tolerability of PRO-143 solution ophthalmic in healthy volunteers.

Detailed description

A phase I, open label and unicentric clinical trial to evaluate the safety and tolerability of PRO-143 ophthalmic solution in healthy volunteers.

Conditions

• Conjunctivitis, Bacterial

Interventions

Type	Name	Description
DRUG	PRO-143 Ophthalmic Solution	PRO-143 Ophthalmic Solution applied four times per day (C/6 hours) during 10 days.

Timeline

• Start date: 2013-11-01
• Primary completion: 2014-02-01
• Completion: 2014-03-01
• First posted: 2018-10-05
• Last updated: 2018-10-10

Locations

1 site across 1 country: Mexico